Randomised controlled trial of an interactive multimedia decision aid on benign prostatic hypertrophy in primary care
- PMID: 11532845
- PMCID: PMC48138
- DOI: 10.1136/bmj.323.7311.493
Randomised controlled trial of an interactive multimedia decision aid on benign prostatic hypertrophy in primary care
Abstract
Objective: To determine whether a decision aid on benign prostatic hypertrophy influences decision making, health outcomes, and resource use.
Design: Randomised controlled trial.
Setting: 33 general practices in the United Kingdom.
Participants: 112 men with benign prostatic hypertrophy.
Intervention: Patients' decision aid consisting of an interactive multimedia programme with booklet and printed summary.
Outcome measures: Patients' and general practitioners' perceptions of who made the decision, decisional conflict scores, treatment choice and prostatectomy rate, American Urological Association symptom scale, costs, anxiety, utility, and general health status.
Results: Both patients and general practitioners found the decision aid acceptable. A higher proportion of patients (32% v 4%; mean difference 28%, 95% confidence interval 14% to 41%) and their general practitioners (46% v 25%; 21%, 3% to 40%) perceived that treatment decisions had been made mainly or only by patients in the intervention group compared with the control group. Patients in the intervention group had significantly lower decisional conflict scores than those in the control group at three months (2.3 v 2.6; -0.3, -0.5 to -0.1, P<0.01) and this was maintained at nine months. No differences were found between the groups for anxiety, general health status, prostatic symptoms, utility, or costs (excluding costs associated with the video disc equipment).
Conclusions: The decision aid reduced decisional conflict in men with benign prostatic hypertrophy, and the patients played a more active part in decision making. Such programmes could be delivered cheaply by the internet, and there are good arguments for coordinated investment in them, particularly for conditions in which patient utilities are important.
Comment in
-
A key medical decision maker: the patient.BMJ. 2001 Sep 1;323(7311):466-7. doi: 10.1136/bmj.323.7311.466. BMJ. 2001. PMID: 11532825 Free PMC article. No abstract available.
-
Use of interactive multimedia decision aids. Alternative explanation for results may exist.BMJ. 2002 Feb 2;324(7332):296; author reply 296. doi: 10.1136/bmj.324.7332.296b. BMJ. 2002. PMID: 11823368 Free PMC article. No abstract available.
-
Use of interactive multimedia decision aids. Discrepancy may exist between GPs and their patients about who is making the decisions.BMJ. 2002 Feb 2;324(7332):296; author reply 296. BMJ. 2002. PMID: 11936134 No abstract available.
References
-
- Barry MJ, Fowler FJJ, Mulley AGJ, Henderson JVJ, Wennberg JE. Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia. Med Care. 1995;33:771–782. - PubMed
-
- Barry MJ, Cherkin DC, Chang Y, Fowler FJJ, Skates S. A randomized trial of a multimedia shared decision-making program for men facing a treatment decision for benign prostatic hyperplasia. Dis Manage Clin Outcomes. 1997;1:5–14.
-
- Kasper JF, Mulley AGJ, Wennberg JE. Developing shared decision-making programs to improve the quality of health care. Qual Rev Bull. 1992;18:183–190. - PubMed
-
- McConnell JD, Barry MJ, Bruskewitz RC. Benign prostatic hyperplasia: diagnosis and treatment. Rockville, MD: Agency for Health Care Policy and Research; 1994. . (Clinical practice guideline No 8.) - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical